In the BioHarmony Drug Report Database
Lithium carbonate
Eskalith, Lithane, Lithium Carbonate, Lithobid, Lithonate, Lithotabs (lithium carbonate) is a small molecule pharmaceutical. Lithium carbonate was first approved as Eskalith on 1982-01-01. It is used to treat bipolar disorder, conduct disorder, depressive disorder, and post-traumatic stress disorders in the USA. The pharmaceutical is active against inositol monophosphatase 1. In addition, it is known to target glycogen synthase kinase-3 beta.
Trade Name
|
Eskalith, Lithane, Lithium Carbonate, Lithobid, Lithonate, Lithotabs |
|---|---|
Common Name
|
lithium carbonate |
ChEMBL ID
|
CHEMBL1200826 |
Indication
|
bipolar disorder, conduct disorder, depressive disorder, post-traumatic stress disorders |
Drug Class
|
Image (chem structure or protein)